[Administration of surfactant in hyaline membrane disease].
Valls i Soler
A
A
Unidad Neonatal, Hospital Infantil de Cruces, Universidad del País Vasco, Baracaldo, Vizcaya.
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000627:therapeutic use; D000818:Animals; D002417:Cattle; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy*; D007231:Infant, Newborn; D010715:Phosphatidylglycerols / Q000627:therapeutic use; D010716:Phosphatidylinositols / Q000627:therapeutic use; D011663:Pulmonary Surfactants / Q000009:adverse effects / Q000627:therapeutic use*
D010715:Phosphatidylglycerols; D010716:Phosphatidylinositols; D011663:Pulmonary Surfactants; D015060:1,2-Dipalmitoylphosphatidylcholine
Administración de surfactante en la enfermedad de la membrana hiliana.